The Use of Alfaxalone in Quaker Parrots (Myiopsitta monachus)

Abstract: Alfaxalone is a neurosteroid anesthetic that acts on gamma-aminobutyric acid alpha-receptors. The objective of this study was to evaluate the clinical safety and efficacy of alfaxalone (Alfaxan CD). Due to observed hyperexcitability in the subject animals when alfaxalone was the only drug used during the initial trials, premedication with midazolam was also evaluated during the final study. Ten adult Quaker parrots (Myiopsitta monachus) were assigned to 3 groups: 1) low-dose alfaxalone 10 mg/kg (LD), 2) high-dose alfaxalone 25 mg/kg (HD), and 3) alfaxalone 10 mg/ kg with midazolam 1 mg/kg premedication (AM), administered intramuscularly. Induction time, sedation quality, duration of action, and vital parameters, including heart rate, respiratory rate, and temperature, were recorded. All protocols achieved adequate sedation; however, muscle tremors and hyperexcitation were variable. The LD group had a significantly longer mean ± SD induction time (13.5 ± 4.5 minutes) as compared to the HD (6.0 ± 1.3 minutes, P = .002) and AM (6.5 ± 2.9 minutes, P = .006) groups, while recovery time was significantly longer in the HD group (86.2 ± 13.4 minutes) than the LD group (44.4 ± 10.8 minutes, P < .001). Midazolam premedication resulted in reduction of both muscle tremors and hyperexcitation associated with alfaxalone administration, but the recovery time was significantly longer (103.5 ± 15.1 minutes, P < .001) than for the LD group. Alfaxalone as a sole agent resulted in muscle tremors and hyperexcitation during induction, which was attenuated by premedication with midazolam. Further investigation is warranted to characterize the effects of alfaxalone and drugs used to premedicate Quaker parrots.

[1]  D. Lindemann,et al.  Evaluation of the anesthetic and cardiorespiratory effects of intramuscular alfaxalone administration and isoflurane in budgerigars (Melopsittacus undulatus) and comparison with manual restraint. , 2019, Journal of the American Veterinary Medical Association.

[2]  D. Mellor,et al.  Effects of noxious stimuli on the electroencephalogram of anaesthetised chickens (Gallus gallus domesticus) , 2018, PloS one.

[3]  M. Bertelsen,et al.  CARDIOVASCULAR EFFECTS OF ALFAXALONE AND PROPOFOL IN THE BULLFROG, LITHOBATES CATESBEIANUS , 2018, Journal of Zoo and Wildlife Medicine.

[4]  K. Yamashita,et al.  Anesthetic and cardiorespiratory effects of single-bolus intravenous alfaxalone with or without intramuscular xylazine-premedication in calves , 2017, The Journal of veterinary medical science.

[5]  A. F. Thomsen,et al.  ALFAXALONE ANESTHESIA IN THE BENGALESE FINCH (LONCHURA DOMESTICA) , 2017, Journal of Zoo and Wildlife Medicine.

[6]  M. Kubiak,et al.  The Influence of a Combined Butorphanol and Midazolam Premedication on Anesthesia in Psittacid Species , 2016, Journal of Avian Medicine and Surgery.

[7]  P. Langer,et al.  Evaluation of the anesthetic efficacy of alfaxalone in oscar fish (Astronotus ocellatus). , 2016, American journal of veterinary research.

[8]  S. Robertson,et al.  Veterinary anesthesia and analgesia , 2015 .

[9]  C. Harms,et al.  ALFAXALONE AS AN INTRAMUSCULAR INJECTABLE ANESTHETIC IN KOI CARP (CYPRINUS CARPIO) , 2014, Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians.

[10]  G. Le Teuff,et al.  Intramuscular administration of alfaxalone for sedation in rabbits , 2014, Veterinary Record.

[11]  Z. Knotek.  Alfaxalone as an induction agent for anaesthesia in terrapins and tortoises , 2014, Veterinary Record.

[12]  S. Villaverde-Morcillo,et al.  COMPARISON OF ISOFLURANE AND ALFAXALONE (ALFAXAN) FOR THE INDUCTION OF ANESTHESIA IN FLAMINGOS (PHOENICOPTERUS ROSEUS) UNDERGOING ORTHOPEDIC SURGERY , 2014, Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians.

[13]  E. Hofmeister,et al.  Pharmacodynamics of alfaxalone after single-dose intramuscular administration in red-eared sliders (Trachemys scripta elegans): a comparison of two different doses at two different ambient temperatures. , 2013, Veterinary anaesthesia and analgesia.

[14]  M. Bellingham,et al.  Plasma pharmacokinetics of alfaxalone after a single intraperitoneal or intravenous injection of Alfaxan(®) in rats. , 2013, Journal of veterinary pharmacology and therapeutics.

[15]  D. Phalen,et al.  Preliminary studies of alfaxalone for intravenous immobilization of juvenile captive estuarine crocodiles (Crocodylus porosus) and Australian freshwater crocodiles (Crocodylus johnstoni) at optimal and selected sub-optimal thermal zones. , 2013, Veterinary anaesthesia and analgesia.

[16]  A. B. Sadegh.  COMPARISON OF INTRANASAL ADMINISTRATION OF XYLAZINE, DIAZEPAM, AND MIDAZOLAM IN BUDGERIGARS (MELOPSITTACUS UNDULATUS): CLINICAL EVALUATION , 2013, Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians.

[17]  M. Bertelsen,et al.  Intramuscular administration of alfaxalone in red-eared sliders (Trachemys scripta elegans)--effects of dose and body temperature. , 2013, Veterinary anaesthesia and analgesia.

[18]  Krista L. Jones.  Therapeutic Review: Alfaxalone , 2012 .

[19]  J. Paul-Murphy,et al.  Sedation and Physiologic Response to Manual Restraint After Intranasal Administration of Midazolam in Hispaniolan Amazon Parrots (Amazona ventralis) , 2012 .

[20]  M. Bertelsen,et al.  Alfaxalone anaesthesia in the green iguana (Iguana iguana). , 2011, Veterinary anaesthesia and analgesia.

[21]  P. Murison,et al.  Effect of propofol and alfaxalone on pain after ovariohysterectomy in cats , 2010, Veterinary Record.

[22]  S. Maloney,et al.  Induction of anaesthesia in wild rabbits using a new alfaxalone formulation , 2009, Veterinary Record.

[23]  Laura L. Nelson,et al.  The cardiorespiratory and anesthetic effects of clinical and supraclinical doses of alfaxalone in cats. , 2008, Veterinary anaesthesia and analgesia.

[24]  Laura L. Nelson,et al.  Cardiorespiratory and anesthetic effects of clinical and supraclinical doses of alfaxalone in dogs. , 2008, Veterinary anaesthesia and analgesia.

[25]  T. Whittem,et al.  Plasma pharmacokinetics of alfaxalone in dogs after an intravenous bolus of Alfaxan-CD RTU. , 2006, Veterinary anaesthesia and analgesia.

[26]  C. Goodchild,et al.  Antinociceptive Properties of Neurosteroids: A Comparison of Alphadolone and Alphaxalone in Potentiation of Opioid Antinociception , 2003, Anesthesia and analgesia.

[27]  C. Goodchild,et al.  Antinociceptive properties of neurosteroids III: experiments with alphadolone given intravenously, intraperitoneally, and intragastrically. , 2001, British journal of anaesthesia.

[28]  C. Goodchild,et al.  Antinociceptive properties of neurosteroids II. Experiments with Saffan® and its components alphaxalone and alphadolone to reveal separation of anaesthetic and antinociceptive effects and the involvement of spinal cord GABAA receptors , 2000, Pain.

[29]  K. Machin,et al.  Investigation of Injectable Anesthetic Agents in Mallard Ducks (Anas platyrhynchos): A Descriptive Study , 1998 .

[30]  J. Sear.  Steroid anesthetics: old compounds, new drugs. , 1996, Journal of clinical anesthesia.

[31]  T. Coderre,et al.  Preemptive Analgesic Effects of Steroid Anesthesia with Alphaxalone in the Rat Formalin Test: Evidence for Differential GABA‐A Receptor Modulation in Persistent Nociception , 1996, Anesthesiology.

[32]  L. Cullen,et al.  Ostrich anaesthesia: xylazine premedication followed by alphaxalone/alphadolone and isoflurane. , 1995, Australian veterinary journal.

[33]  M. Gentle,et al.  Physiological and behavioural responses associated with feather removal in Gallus gallus var domesticus. , 1991, Research in veterinary science.

[34]  N. Bodor,et al.  Development of a non-surfactant formulation for alfaxalone through the use of chemically-modified cyclodextrins. , 1989, Journal of parenteral science and technology : a publication of the Parenteral Drug Association.

[35]  J. Sear,et al.  Steroid anaesthesia , 1992, Lancet.

[36]  P. Holt.  The use of a steriod anaesthetic in a long-eared owl (Asio otus) , 1977, Veterinary Record.

[37]  R. Curtis,et al.  Saffan (CT 1341) as an anaesthetic agent for the budgerigar Melopsittacus undulatus. , 1977, The Journal of small animal practice.

[38]  J. Cooper,et al.  Unexpected reactions to the use of CT 1341 by red-tailed hawks , 1975, Veterinary Record.

[39]  J. M. Watt.  Anaphylactic reactions after use of CT 1341 (althesin). , 1975, British medical journal.

[40]  J. P. Currie,et al.  THE PHARMACOLOGICAL PROPERTIES IN ANIMALS OF CT1341—A NEW STEROID ANAESTHETIC AGENT , 1972, British journal of anaesthesia.